AC Immune (ACIU) Enterprise Value (2016 - 2025)
Historic Enterprise Value for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to -$135.6 million.
- AC Immune's Enterprise Value fell 27148.21% to -$135.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.6 million, marking a year-over-year decrease of 27148.21%. This contributed to the annual value of -$188.9 million for FY2024, which is 9931.97% up from last year.
- Per AC Immune's latest filing, its Enterprise Value stood at -$135.6 million for Q3 2025, which was down 27148.21% from -$153.6 million recorded in Q2 2025.
- Over the past 5 years, AC Immune's Enterprise Value peaked at $79.1 million during Q3 2024, and registered a low of -$125.9 billion during Q4 2021.
- For the 5-year period, AC Immune's Enterprise Value averaged around -$12.0 billion, with its median value being -$127.2 million (2022).
- In the last 5 years, AC Immune's Enterprise Value plummeted by 5951971.46% in 2021 and then skyrocketed by 19321.28% in 2024.
- Over the past 5 years, AC Immune's Enterprise Value (Quarter) stood at -$125.9 billion in 2021, then skyrocketed by 99.9% to -$127.2 million in 2022, then plummeted by 21723.36% to -$27.8 billion in 2023, then surged by 99.32% to -$188.9 million in 2024, then grew by 28.22% to -$135.6 million in 2025.
- Its last three reported values are -$135.6 million in Q3 2025, -$153.6 million for Q2 2025, and -$162.0 million during Q1 2025.